Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Quick

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022
Impact of lowering fine particulate matter from major emission sources on mortality in Canada: A nationwide causal analysisHong Chen, Matthew Quick, Jay S Kaufman, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2016
Human papillomavirus type 16 viral load is decreased following a therapeutic vaccinationHannah N Coleman, William W Greenfield, Shawna L Stratton, et al.
Oncoimmunology|October 10, 2015
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>Candida</i> skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3William W Greenfield, Shawna L Stratton, Rebecca S Myrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transitionSiming Zhao, Stefania Bellone, Salvatore Lopez, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022
Impact of lowering fine particulate matter from major emission sources on mortality in Canada: A nationwide causal analysisHong Chen, Matthew Quick, Jay S Kaufman, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2016
Human papillomavirus type 16 viral load is decreased following a therapeutic vaccinationHannah N Coleman, William W Greenfield, Shawna L Stratton, et al.
Oncoimmunology|October 10, 2015
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>Candida</i> skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3William W Greenfield, Shawna L Stratton, Rebecca S Myrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transitionSiming Zhao, Stefania Bellone, Salvatore Lopez, et al.
Pageof 3